Market revenue in 2023 | USD 13.0 million |
Market revenue in 2030 | USD 21.3 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.69% in 2023. Horizon Databook has segmented the Middle East & Africa clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
This market encompasses various countries in the MEA region, including Saudi Arabia, United Arab Emirates, South Africa, and others. The demand for patient recruitment services in this region is driven by the increasing number of clinical trials, particularly in emerging markets, and the need for efficient and targeted patient recruitment strategies.
Companies offering patient recruitment services in the MEA region play a vital role in assisting clinical trial sponsors with identifying and enrolling eligible participants, ensuring the successful execution of clinical trials in this region.
Conducting clinical trials in the MEA can offer several advantages, including patient diversity, cost savings, infrastructure, and world-class medical facilities. The number of CROs in the UAE has increased since 2000.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa clinical trial patient recruitment services market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account